Skip to main content
. 2022 Sep 27;19(19):12221. doi: 10.3390/ijerph191912221

Table 3.

Differences in clinical and demographic characteristics of NAFLD and MAFLD criteria in patients with BMI < 25 kg/m2.

Characteristic Lean NAFLD
(n= 273)
% (n)/μ ± SD
Lean MAFLD
(n = 118)
% (n)/μ ± SD
p Effect Size (Cohen’s d/w)
Male 56.8 (155) 52.5 (62) 0.44 0.92 Large
Age (years) 50.7 ± 9.9 52.7 ± 10.5 0.07 −0.06 Null
DM 4.8 (13) 10.2 (12) 0.06 0.99 Large
HBP 10.3 (28) 17.8 (21) 0.04 0.98 Large
BMI (kg/m2) 23.4 ± 1.8 23.3 ± 2.4 0.65 −0.69 Null
Glucose (g/dL) 94.2 ± 16.5 98.9 ± 22.2 0.02 −0.40 Null
HbA1c (%) 5.4 ± 0.6 5.5 ± 0.7 0.15 −0.39 Null
SBP (mmHg) 110.4 ± 14.1 114.3 ± 13.8 0.01 −0.31 Null
DBP (mmHg) 72.4 ± 9.2 74.7 ± 9.6 0.02 −0.36 Null
Triglycerides (mg/dL) 138.8 ± 81.1 184.2 ± 95.8 <0.0001 −0.37 Null
HDL (mg/dL) 48.1 ± 12.7 43.2 ± 12.6 0.0005 0.23 Small
CRP 2.8 ± 18.3 5.2 ± 27.7 0.31 −0.14 Null
WC (cm) 87.7 ± 7.0 88.7 ± 7.9 0.21 −0.75 Null
CAP (dB/m) 291.9 ± 26.5 296.3 ± 27.9 0.13 −2.24 Null
   S1 45.1 (123) 37.3 (44) 0.18 0.94 Large
   S2 17.2 (47) 21.2 (25) 0.39 0.97 Large
   S3 34.8 (95) 39.8 (47) 0.36 0.95 Large
kPa 4.0 ± 0.8 4.1 ± 0.8 0.257 −0.25 Null
Glucose abnormalities 26.4 (72) 44.9 (53) 0.004 0.95 Large
HBP abnormalities 17.2 (47) 31.4 (37) 0.003 0.97 Large
Triglycerides >150 32.6 (89) 62.7 (74) 0.0001 0.94 Large
HDL abnormalities 35.5 (97) 62.7 (74) 0.0001 0.94 Large
CRP > 2.0 23.8 (65) 44.9 (53) 0.0001 0.96 Large
WC abnormalities 10.3 (28) 18.6 (22) 0.03 0.98 Large

DM: diabetes mellitus; HBP: high blood pressure; BMI: body mass index; HbA1C: glycosylated hemoglobin; SBP: systolic blood pressure; DBP: diastolic blood pressure; HDL: high density lipoprotein; CRP: C reactive protein; WC: waist circumference; CAP: controlled attenuation parameter.